 LAUSANNE, Switzerland, Feb. 02, 2022 GLOBE NEWSWIRE -- AC Immune SA NASDAQ: ACIU, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company management will participate in a fireside chat and one-on-one investor meetings during the SVB Leerink 11th Annual Global Healthcare Conference, taking place virtually February 14-18, 2022. 